These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11983946)
1. Optimized combination of antiplatelet treatment and anticoagulation for percutaneous coronary intervention: the final word is not out yet! Gruberg L; Beyar R J Invasive Cardiol; 2002 May; 14(5):251-3. PubMed ID: 11983946 [No Abstract] [Full Text] [Related]
2. Challenges of antiplatelet therapy in patients who require anticoagulation. Henkel DM; Holmes DR J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758 [No Abstract] [Full Text] [Related]
3. Optimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stenting. Zinn A; Feit F Am J Cardiol; 2009 Sep; 104(5 Suppl):49C-54C. PubMed ID: 19695362 [TBL] [Abstract][Full Text] [Related]
4. Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation. Rubboli A; Colletta M; Di Pasquale G Am Heart J; 2005 Feb; 149(2):E1. PubMed ID: 15846242 [No Abstract] [Full Text] [Related]
5. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Helft G; Gilard M; Le Feuvre C; Zaman AG Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800 [TBL] [Abstract][Full Text] [Related]
6. Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention. Kelly RV; Steinhubl S Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii16-9. PubMed ID: 15919646 [No Abstract] [Full Text] [Related]
7. The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts. D'Agate DJ; Patel S; Coppola JT; Ambrose JA J Invasive Cardiol; 2004 Sep; 16(9):500-3. PubMed ID: 15353833 [No Abstract] [Full Text] [Related]
8. Hazard--the anticoagulation bridge or just go transradial. Gilchrist IC Catheter Cardiovasc Interv; 2009 Jan; 73(1):48-9. PubMed ID: 19089937 [No Abstract] [Full Text] [Related]
9. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Gilard M; Blanchard D; Helft G; Carrier D; Eltchaninoff H; Belle L; Finet G; Le Breton H; Boschat J; Am J Cardiol; 2009 Aug; 104(3):338-42. PubMed ID: 19616664 [TBL] [Abstract][Full Text] [Related]
10. Applying drug-eluting stents in clinical practice. King SB Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous coronary artery dissection and the role for percutaneous coronary intervention: to treat or not to treat? Chue CD; Routledge HC; Townend JN J Invasive Cardiol; 2009 Mar; 21(3):E44-7. PubMed ID: 19258650 [TBL] [Abstract][Full Text] [Related]
12. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Bhatt DL Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708 [TBL] [Abstract][Full Text] [Related]